Peptides Codex
Home
Cyclic lipopeptide antibiotic

Colistin

Colistin, also called polymyxin E, is a cyclic lipopeptide antibiotic from Paenibacillus species and a close relative of polymyxin B. It displaces divalent cations from lipopolysaccharide phosphate groups, breaking down the Gram-negative outer membrane. Classified by the WHO as critically important and reserved as a last-resort drug, its usefulness is threatened by the mobile mcr-1 resistance gene. This page is educational and not medical advice.

By The Peptides Codex Editorial TeamReviewed July 10, 2026
Length
n/a
Class
Cyclic lipopeptide antibiotic
Function
Binds lipid A and permeabilizes the Gram-negative outer membrane
Context
Last-resort approved antibiotic for multidrug-resistant Gram-negative infections

Polymyxin E — a last-resort agent whose plasmid-borne mcr-1 resistance gene raised global alarm.

Also known as: polymyxin E · colistimethate (prodrug)

Part of the Foundational & therapeutic peptides cluster

Overview

Colistin, also called polymyxin E, is a cyclic lipopeptide antibiotic from Paenibacillus species and a close relative of polymyxin B. It displaces divalent cations from lipopolysaccharide phosphate groups, breaking down the Gram-negative outer membrane. Classified by the WHO as critically important and reserved as a last-resort drug, its usefulness is threatened by the mobile mcr-1 resistance gene. This page is educational and not medical advice.

Source & context

Biological / chemical source: Bacteria of the genus Paenibacillus (Paenibacillus polymyxa)

Primary research or clinical context: Last-resort approved antibiotic for multidrug-resistant Gram-negative infections

How it works

Like polymyxin B, colistin is a polycationic cyclic lipopeptide rich in diaminobutyric acid. It competitively displaces Ca2+ and Mg2+ that bridge neighboring lipopolysaccharide molecules, destabilizing the outer membrane and causing leakage and death of Gram-negative bacteria. It is administered as the less-toxic prodrug colistimethate sodium.

Resistance concern

Discovered in 1947, colistin was sidelined by toxicity, then revived against carbapenem-resistant organisms. The 2015 discovery of the plasmid-borne mcr-1 gene, which spreads colistin resistance between bacteria, made stewardship of this last-resort drug a major public-health topic.

FAQ about Colistin

What is Colistin?+

Colistin, also called polymyxin E, is a cyclic lipopeptide antibiotic from Paenibacillus species and a close relative of polymyxin B. It displaces divalent cations from lipopolysaccharide phosphate groups, breaking down the Gram-negative outer membrane. Classified by the WHO as critically important and reserved as a last-resort drug, its usefulness is threatened by the mobile mcr-1 resistance gene. This page is educational and not medical advice.

Is Colistin an approved medicine?+

Colistin: Last-resort approved antibiotic for multidrug-resistant Gram-negative infections. Always follow licensed medical guidance for approved products.

What is the typical length of Colistin?+

Colistin is not a classic amino-acid chain peptide in the same sense; see the profile for classification details.

Related peptides

References & further reading

  1. 1.Wikipedia — Colistin
  2. 2.PubChem — compound summary for Colistin (CID 5311054)
Disclaimer: Educational content only. Not medical advice. Not instructions for human use. Research peptides and unapproved products may be restricted or illegal to market for human consumption in your jurisdiction. Consult qualified professionals and applicable law.
You might also like: All peptides · Atlas · Research · Tools
Cite this: Peptides Codex — Colistin educational profile.
Tip: Use browser print (Ctrl/Cmd + P) for a clean PDF of this page.